Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-butyl-2-(hydroxylmethyl)piperidine-3,4,5-triol
2. 1-deoxy-galactonojirimycin
3. 1-deoxygalacto-nojirimycin
4. 1-deoxygalactonojirimycin
5. At1001 Deoxyjirimycin
6. Galafold
7. Gr181413a
8. Migalastat
9. Migalastat Hcl
10. Migalastat Hydrochloride
11. N-butyldeoxygalacto-nojirimycin
12. N-butyldeoxygalactonojirimycin
13. Nb-dgj
1. 141206-42-0
2. (2r,3s,4r,5s)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
3. N-(n-butyl)deoxygalactonojirimycin
4. Lucerastat [inn]
5. Lucerastat [usan]
6. Act-434964
7. Gvs3ydm418
8. Chembl1086997
9. N-butyldeoxygalactonojirimycin
10. N-butyl-dgj
11. Unii-gvs3ydm418
12. Nbdgj
13. N-bu-dgj
14. Nb-dgj
15. Lucerastat [jan]
16. Lucerastat [usan:inn]
17. Lucerastat (jan/usan/inn)
18. N- Butyldeoxygalactonojirimycin
19. Schembl6821044
20. N-butyl-deoxy-galactonojirimycin
21. Cdp-923
22. Dtxsid60161601
23. N-n-butyl Deoxygalactonojirimycin
24. Ogt-923
25. Who 9539
26. Bdbm50312528
27. Mfcd00269939
28. Zinc13719785
29. N-butyl-d-galacto-1-deoxynojirimycin
30. Db14872
31. Ncgc00181326-01
32. Hy-106392
33. Cs-0025710
34. D11439
35. 1-butyl-2-hydroxymethyl-piperidine-3,4,5-triol
36. W-201205
37. Q27279309
38. (2r,3s,4r,5s)-1-butyl-2-(hydroxymethyl)-3,4,5-piperidinetriol
39. (2r,3s,4r,5s)-1-(but-1-yl)-2-(hydroxymethyl)piperidine-3,4,5-triol
40. 3,4,5-piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2r,3s,4r,5s)-
| Molecular Weight | 219.28 g/mol |
|---|---|
| Molecular Formula | C10H21NO4 |
| XLogP3 | -0.6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 219.14705815 g/mol |
| Monoisotopic Mass | 219.14705815 g/mol |
| Topological Polar Surface Area | 84.2 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 190 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Treatment of Fabry disease
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Lucerastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lucerastat, including repackagers and relabelers. The FDA regulates Lucerastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lucerastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lucerastat supplier is an individual or a company that provides Lucerastat active pharmaceutical ingredient (API) or Lucerastat finished formulations upon request. The Lucerastat suppliers may include Lucerastat API manufacturers, exporters, distributors and traders.
Lucerastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lucerastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lucerastat GMP manufacturer or Lucerastat GMP API supplier for your needs.
A Lucerastat CoA (Certificate of Analysis) is a formal document that attests to Lucerastat's compliance with Lucerastat specifications and serves as a tool for batch-level quality control.
Lucerastat CoA mostly includes findings from lab analyses of a specific batch. For each Lucerastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lucerastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Lucerastat EP), Lucerastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lucerastat USP).
LOOKING FOR A SUPPLIER?
